ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bacteriophage Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-10G5314
Home | Market Reports | Science| Biological Sciences
Global Bacteriophage Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Bacteriophage Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-10G5314
Report
July 2025
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
NPO Microgen
Proteon Pharmaceuticals
Phagelux Inc.
Micreos BV
Eliava BioPreparations
Locus Biosciences，Inc
Pharmex Group，LLC
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
MicroMir
iNtoDEWorld
Armata Pharmaceuticals, Inc.
TechnoPhage
Intralytix
PhagePro, Inc.
BiomX
Phaxiam Therapeutics
ACD Pharma
NexaBiome Limited

Bacteriophage Market Size

In 2024, the global market size of Bacteriophage was estimated to be worth US$ 52.3 million and is forecast to reach approximately US$ 177 million by 2031 with a CAGR of 19.3% during the forecast period 2025-2031.

Bacteriophage Market

Bacteriophage Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Bacteriophage Market Report

Report Metric Details
Report Name Bacteriophage Market
CAGR 19.3%
Segment by Type
Segment by Application
  • Animal Health
  • Aquaculture
  • Agriculture
  • Food Industry
  • Human Health
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), ACD Pharma, Proteon Pharmaceuticals, Micreos, Locus Biosciences, Inc, NexaBiome Limited, PhagePro, BiomX, INtODEWORLD, Inc., TechnoPhage
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Bacteriophage in global and regional level.
  • Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the market share of major companies in Bacteriophage Market?

Ans: The top three players hold a share about 34%.

What is the Bacteriophage Market share by region?

Ans: Europe is the largest market, has a share about 48%.

What is the Bacteriophage Market share by type?

Ans: In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%.

Who are the main players in the Bacteriophage Market report?

Ans: The main players in the Bacteriophage Market are NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), ACD Pharma, Proteon Pharmaceuticals, Micreos, Locus Biosciences, Inc, NexaBiome Limited, PhagePro, BiomX, INtODEWORLD, Inc., TechnoPhage

What are the Application segmentation covered in the Bacteriophage Market report?

Ans: The Applications covered in the Bacteriophage Market report are Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others

What are the Type segmentation covered in the Bacteriophage Market report?

Ans: The Types covered in the Bacteriophage Market report are DsDNA Bacteriophage, SsDNA Bacteriophage, SsRNA Bacteriophage, Others

Recommended Reports

Infectious Disease Treatment

Biopharmaceutical Ingredients

Gene and Microbial Therapy

1 Study Coverage
1.1 Bacteriophage Product Introduction
1.2 Market by Type
1.2.1 Global Bacteriophage Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bacteriophage Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bacteriophage Market Size Estimates and Forecasts
2.2 Bacteriophage Market Size by Region: 2024 Versus 2031
2.2.1 Global Bacteriophage Revenue by Region: 2020-2025
2.2.2 Global Bacteriophage Revenue Forecast by Region (2026-2031)
2.2.3 Global Bacteriophage Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Bacteriophage Revenue by Type (2020-2031)
3.1.2 Global Bacteriophage Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Bacteriophage Revenue by Application (2020-2031)
3.2.2 Global Bacteriophage Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 DsDNA Bacteriophage of Bacteriophage Revenue Market Share by Application
3.3.2 SsDNA Bacteriophage of Bacteriophage Revenue Market Share by Application
3.3.3 SsRNA Bacteriophage of Bacteriophage Revenue Market Share by Application
3.3.4 Others of Bacteriophage Revenue Market Share by Application
4 Global Bacteriophage by Company
4.1 Global Bacteriophage Revenue by Company (2020-2025)
4.2 Global Bacteriophage Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Bacteriophage Companies around the World: Ranking by Revenue
4.3.2 Global Bacteriophage Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Bacteriophage Companies Headquarters & Product Type
4.4.1 Global Bacteriophage Companies Headquarters
4.4.2 Date of International Companies Enter into Bacteriophage Market
4.4.3 Global Bacteriophage Companies Product & Service
4.4.4 DsDNA Bacteriophage Revenue Market Share of Bacteriophage by Company
4.4.5 SsDNA Bacteriophage Revenue Market Share of Bacteriophage by Company
4.4.6 SsRNA Bacteriophage Revenue Market Share of Bacteriophage by Company
4.4.7 Others Revenue Market Share of Bacteriophage by Company
4.5 Global Bacteriophage Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 NPO Microgen
5.1.1 NPO Microgen Corporation Information
5.1.2 NPO Microgen Description, Business Overview
5.1.3 NPO Microgen Bacteriophage Products Offered
5.1.4 NPO Microgen Bacteriophage Revenue and Gross Margin (2020-2025)
5.1.5 NPO Microgen Bacteriophage Revenue by Product in 2024
5.1.6 NPO Microgen Bacteriophage Revenue by Application in 2024
5.1.7 NPO Microgen Bacteriophage Revenue by Geographic Area in 2024
5.1.8 NPO Microgen Recent Developments
5.2 Qingdao Phagepharm Bio-tech
5.2.1 Qingdao Phagepharm Bio-tech Corporation Information
5.2.2 Qingdao Phagepharm Bio-tech Description, Business Overview
5.2.3 Qingdao Phagepharm Bio-tech Bacteriophage Products Offered
5.2.4 Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin (2020-2025)
5.2.5 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Product in 2024
5.2.6 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Application in 2024
5.2.7 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Geographic Area in 2024
5.2.8 Qingdao Phagepharm Bio-tech Recent Developments
5.3 Armata Pharmaceuticals, Inc.
5.3.1 Armata Pharmaceuticals, Inc. Corporation Information
5.3.2 Armata Pharmaceuticals, Inc. Description, Business Overview
5.3.3 Armata Pharmaceuticals, Inc. Bacteriophage Products Offered
5.3.4 Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
5.3.5 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Product in 2024
5.3.6 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Application in 2024
5.3.7 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Geographic Area in 2024
5.3.8 Armata Pharmaceuticals, Inc. Recent Developments
5.4 Phaxiam Therapeutics
5.4.1 Phaxiam Therapeutics Corporation Information
5.4.2 Phaxiam Therapeutics Description, Business Overview
5.4.3 Phaxiam Therapeutics Bacteriophage Products Offered
5.4.4 Phaxiam Therapeutics Bacteriophage Revenue and Gross Margin (2020-2025)
5.4.5 Phaxiam Therapeutics Bacteriophage Revenue by Product in 2024
5.4.6 Phaxiam Therapeutics Bacteriophage Revenue by Application in 2024
5.4.7 Phaxiam Therapeutics Bacteriophage Revenue by Geographic Area in 2024
5.4.8 Phaxiam Therapeutics Recent Developments
5.5 Eliava BioPreparations
5.5.1 Eliava BioPreparations Corporation Information
5.5.2 Eliava BioPreparations Description, Business Overview
5.5.3 Eliava BioPreparations Bacteriophage Products Offered
5.5.4 Eliava BioPreparations Bacteriophage Revenue and Gross Margin (2020-2025)
5.5.5 Eliava BioPreparations Bacteriophage Revenue by Product in 2024
5.5.6 Eliava BioPreparations Bacteriophage Revenue by Application in 2024
5.5.7 Eliava BioPreparations Bacteriophage Revenue by Geographic Area in 2024
5.5.8 Eliava BioPreparations Recent Developments
5.6 Intralytix
5.6.1 Intralytix Corporation Information
5.6.2 Intralytix Description, Business Overview
5.6.3 Intralytix Bacteriophage Products Offered
5.6.4 Intralytix Bacteriophage Revenue and Gross Margin (2020-2025)
5.6.5 Intralytix Bacteriophage Revenue by Product in 2024
5.6.6 Intralytix Bacteriophage Revenue by Application in 2024
5.6.7 Intralytix Bacteriophage Revenue by Geographic Area in 2024
5.6.8 Intralytix Recent Developments
5.7 MicroMir
5.7.1 MicroMir Corporation Information
5.7.2 MicroMir Description, Business Overview
5.7.3 MicroMir Bacteriophage Products Offered
5.7.4 MicroMir Bacteriophage Revenue and Gross Margin (2020-2025)
5.7.5 MicroMir Bacteriophage Revenue by Product in 2024
5.7.6 MicroMir Bacteriophage Revenue by Application in 2024
5.7.7 MicroMir Bacteriophage Revenue by Geographic Area in 2024
5.7.8 MicroMir Recent Developments
5.8 Phagelux
5.8.1 Phagelux Corporation Information
5.8.2 Phagelux Description, Business Overview
5.8.3 Phagelux Bacteriophage Products Offered
5.8.4 Phagelux Bacteriophage Revenue and Gross Margin (2020-2025)
5.8.5 Phagelux Bacteriophage Revenue by Product in 2024
5.8.6 Phagelux Bacteriophage Revenue by Application in 2024
5.8.7 Phagelux Bacteriophage Revenue by Geographic Area in 2024
5.8.8 Phagelux Recent Developments
5.9 Pharmex Group, LLC
5.9.1 Pharmex Group, LLC Corporation Information
5.9.2 Pharmex Group, LLC Description, Business Overview
5.9.3 Pharmex Group, LLC Bacteriophage Products Offered
5.9.4 Pharmex Group, LLC Bacteriophage Revenue and Gross Margin (2020-2025)
5.9.5 Pharmex Group, LLC Bacteriophage Revenue by Product in 2024
5.9.6 Pharmex Group, LLC Bacteriophage Revenue by Application in 2024
5.9.7 Pharmex Group, LLC Bacteriophage Revenue by Geographic Area in 2024
5.9.8 Pharmex Group, LLC Recent Developments
5.10 APS Biocontrol Ltd. (APS)
5.10.1 APS Biocontrol Ltd. (APS) Corporation Information
5.10.2 APS Biocontrol Ltd. (APS) Description, Business Overview
5.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Products Offered
5.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin (2020-2025)
5.10.5 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Product in 2024
5.10.6 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Application in 2024
5.10.7 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Geographic Area in 2024
5.10.8 APS Biocontrol Ltd. (APS) Recent Developments
5.11 ACD Pharma
5.11.1 ACD Pharma Corporation Information
5.11.2 ACD Pharma Description, Business Overview
5.11.3 ACD Pharma Bacteriophage Products Offered
5.11.4 ACD Pharma Bacteriophage Revenue and Gross Margin (2020-2025)
5.11.5 ACD Pharma Bacteriophage Revenue by Product in 2024
5.11.6 ACD Pharma Bacteriophage Revenue by Application in 2024
5.11.7 ACD Pharma Bacteriophage Revenue by Geographic Area in 2024
5.11.8 ACD Pharma Recent Developments
5.12 Proteon Pharmaceuticals
5.12.1 Proteon Pharmaceuticals Corporation Information
5.12.2 Proteon Pharmaceuticals Description, Business Overview
5.12.3 Proteon Pharmaceuticals Bacteriophage Products Offered
5.12.4 Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin (2020-2025)
5.12.5 Proteon Pharmaceuticals Bacteriophage Revenue by Product in 2024
5.12.6 Proteon Pharmaceuticals Bacteriophage Revenue by Application in 2024
5.12.7 Proteon Pharmaceuticals Bacteriophage Revenue by Geographic Area in 2024
5.12.8 Proteon Pharmaceuticals Recent Developments
5.13 Micreos
5.13.1 Micreos Corporation Information
5.13.2 Micreos Description, Business Overview
5.13.3 Micreos Bacteriophage Products Offered
5.13.4 Micreos Bacteriophage Revenue and Gross Margin (2020-2025)
5.13.5 Micreos Bacteriophage Revenue by Product in 2024
5.13.6 Micreos Bacteriophage Revenue by Application in 2024
5.13.7 Micreos Bacteriophage Revenue by Geographic Area in 2024
5.13.8 Micreos Recent Developments
5.14 Locus Biosciences, Inc
5.14.1 Locus Biosciences, Inc Corporation Information
5.14.2 Locus Biosciences, Inc Description, Business Overview
5.14.3 Locus Biosciences, Inc Bacteriophage Products Offered
5.14.4 Locus Biosciences, Inc Bacteriophage Revenue and Gross Margin (2020-2025)
5.14.5 Locus Biosciences, Inc Bacteriophage Revenue by Product in 2024
5.14.6 Locus Biosciences, Inc Bacteriophage Revenue by Application in 2024
5.14.7 Locus Biosciences, Inc Bacteriophage Revenue by Geographic Area in 2024
5.14.8 Locus Biosciences, Inc Recent Developments
5.15 NexaBiome Limited
5.15.1 NexaBiome Limited Corporation Information
5.15.2 NexaBiome Limited Description, Business Overview
5.15.3 NexaBiome Limited Bacteriophage Products Offered
5.15.4 NexaBiome Limited Bacteriophage Revenue and Gross Margin (2020-2025)
5.15.5 NexaBiome Limited Bacteriophage Revenue by Product in 2024
5.15.6 NexaBiome Limited Bacteriophage Revenue by Application in 2024
5.15.7 NexaBiome Limited Bacteriophage Revenue by Geographic Area in 2024
5.15.8 NexaBiome Limited Recent Developments
5.16 PhagePro
5.16.1 PhagePro Corporation Information
5.16.2 PhagePro Description, Business Overview
5.16.3 PhagePro Bacteriophage Products Offered
5.16.4 PhagePro Bacteriophage Revenue and Gross Margin (2020-2025)
5.16.5 PhagePro Bacteriophage Revenue by Product in 2024
5.16.6 PhagePro Bacteriophage Revenue by Application in 2024
5.16.7 PhagePro Bacteriophage Revenue by Geographic Area in 2024
5.16.8 PhagePro Recent Developments
5.17 BiomX
5.17.1 BiomX Corporation Information
5.17.2 BiomX Description, Business Overview
5.17.3 BiomX Bacteriophage Products Offered
5.17.4 BiomX Bacteriophage Revenue and Gross Margin (2020-2025)
5.17.5 BiomX Bacteriophage Revenue by Product in 2024
5.17.6 BiomX Bacteriophage Revenue by Application in 2024
5.17.7 BiomX Bacteriophage Revenue by Geographic Area in 2024
5.17.8 BiomX Recent Developments
5.18 INtODEWORLD, Inc.
5.18.1 INtODEWORLD, Inc. Corporation Information
5.18.2 INtODEWORLD, Inc. Description, Business Overview
5.18.3 INtODEWORLD, Inc. Bacteriophage Products Offered
5.18.4 INtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
5.18.5 INtODEWORLD, Inc. Bacteriophage Revenue by Product in 2024
5.18.6 INtODEWORLD, Inc. Bacteriophage Revenue by Application in 2024
5.18.7 INtODEWORLD, Inc. Bacteriophage Revenue by Geographic Area in 2024
5.18.8 INtODEWORLD, Inc. Recent Developments
5.19 TechnoPhage
5.19.1 TechnoPhage Corporation Information
5.19.2 TechnoPhage Description, Business Overview
5.19.3 TechnoPhage Bacteriophage Products Offered
5.19.4 TechnoPhage Bacteriophage Revenue and Gross Margin (2020-2025)
5.19.5 TechnoPhage Bacteriophage Revenue by Product in 2024
5.19.6 TechnoPhage Bacteriophage Revenue by Application in 2024
5.19.7 TechnoPhage Bacteriophage Revenue by Geographic Area in 2024
5.19.8 TechnoPhage Recent Developments
6 North America
6.1 North America Bacteriophage Market Size YoY Growth 2020-2031
6.2 North America Bacteriophage Market Facts & Figures by Country (2020-2031)
6.3 North America Bacteriophage Revenue by Type (2020-2025)
6.4 North America Bacteriophage Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Bacteriophage Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Bacteriophage Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Bacteriophage Revenue by Type (2020-2025)
7.4 Asia-Pacific Bacteriophage Revenue by Application (2020-2025)
8 Europe
8.1 Europe Bacteriophage Market Size YoY Growth 2020-2031
8.2 Europe Bacteriophage Market Facts & Figures by Country (2020-2031)
8.3 Europe Bacteriophage Revenue by Type (2020-2025)
8.4 Europe Bacteriophage Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Bacteriophage Market Size YoY Growth 2020-2031
9.2 Latin America Bacteriophage Market Facts & Figures by Country (2020-2031)
9.3 Latin America Bacteriophage Revenue by Type (2020-2025)
9.4 Latin America Bacteriophage Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Bacteriophage Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Bacteriophage Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Bacteriophage Revenue by Type (2020-2025)
10.4 Middle East and Africa Bacteriophage Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Bacteriophage Supply Chain Analysis
11.2 Bacteriophage Key Raw Materials and Upstream Suppliers
11.3 Bacteriophage Clients Analysis
11.4 Bacteriophage Sales Channel and Sales Model Analysis
11.4.1 Bacteriophage Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Bacteriophage Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Bacteriophage Distributors
12 Bacteriophage Market Dynamics
12.1 Bacteriophage Industry Trends
12.2 Bacteriophage Market Drivers
12.3 Bacteriophage Market Challenges
12.4 Bacteriophage Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
NPO Microgen
Proteon Pharmaceuticals
Phagelux Inc.
Micreos BV
Eliava BioPreparations
Locus Biosciences，Inc
Pharmex Group，LLC
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
MicroMir
iNtoDEWorld
Armata Pharmaceuticals, Inc.
TechnoPhage
Intralytix
PhagePro, Inc.
BiomX
Phaxiam Therapeutics
ACD Pharma
NexaBiome Limited
List of Tables
 Table 1. Global Bacteriophage Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Bacteriophage Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Bacteriophage Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Bacteriophage Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bacteriophage Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Bacteriophage Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Bacteriophage Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Bacteriophage Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Bacteriophage Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Bacteriophage Players by Revenue (US$ Million) in 2024
 Table 13. Global Bacteriophage Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Bacteriophage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage as of 2024)
 Table 15. Global Bacteriophage Companies Headquarters
 Table 16. Date of International Companies Enter into Bacteriophage Market
 Table 17. Global Bacteriophage Companies Product & Service
 Table 18. Global Bacteriophage Mergers & Acquisitions, Expansion Plans
 Table 19. NPO Microgen Corporation Information
 Table 20. NPO Microgen Description and Business Overview
 Table 21. NPO Microgen Bacteriophage Product
 Table 22. NPO Microgen Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. NPO Microgen Revenue Proportion of Bacteriophage by Product in 2024
 Table 24. NPO Microgen Revenue Proportion of Bacteriophage by Application in 2024
 Table 25. NPO Microgen Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 26. NPO Microgen Recent Developments
 Table 27. Qingdao Phagepharm Bio-tech Corporation Information
 Table 28. Qingdao Phagepharm Bio-tech Description and Business Overview
 Table 29. Qingdao Phagepharm Bio-tech Bacteriophage Product
 Table 30. Qingdao Phagepharm Bio-tech Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Qingdao Phagepharm Bio-tech Revenue Proportion of Bacteriophage by Product in 2024
 Table 32. Qingdao Phagepharm Bio-tech Revenue Proportion of Bacteriophage by Application in 2024
 Table 33. Qingdao Phagepharm Bio-tech Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 34. Qingdao Phagepharm Bio-tech Recent Developments
 Table 35. Armata Pharmaceuticals, Inc. Corporation Information
 Table 36. Armata Pharmaceuticals, Inc. Description and Business Overview
 Table 37. Armata Pharmaceuticals, Inc. Bacteriophage Product
 Table 38. Armata Pharmaceuticals, Inc. Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Armata Pharmaceuticals, Inc. Revenue Proportion of Bacteriophage by Product in 2024
 Table 40. Armata Pharmaceuticals, Inc. Revenue Proportion of Bacteriophage by Application in 2024
 Table 41. Armata Pharmaceuticals, Inc. Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 42. Armata Pharmaceuticals, Inc. Recent Developments
 Table 43. Phaxiam Therapeutics Corporation Information
 Table 44. Phaxiam Therapeutics Description and Business Overview
 Table 45. Phaxiam Therapeutics Bacteriophage Product
 Table 46. Phaxiam Therapeutics Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Phaxiam Therapeutics Revenue Proportion of Bacteriophage by Product in 2024
 Table 48. Phaxiam Therapeutics Revenue Proportion of Bacteriophage by Application in 2024
 Table 49. Phaxiam Therapeutics Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 50. Phaxiam Therapeutics Recent Developments
 Table 51. Eliava BioPreparations Corporation Information
 Table 52. Eliava BioPreparations Description and Business Overview
 Table 53. Eliava BioPreparations Bacteriophage Product
 Table 54. Eliava BioPreparations Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Eliava BioPreparations Revenue Proportion of Bacteriophage by Product in 2024
 Table 56. Eliava BioPreparations Revenue Proportion of Bacteriophage by Application in 2024
 Table 57. Eliava BioPreparations Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 58. Eliava BioPreparations Recent Developments
 Table 59. Intralytix Corporation Information
 Table 60. Intralytix Description and Business Overview
 Table 61. Intralytix Bacteriophage Product
 Table 62. Intralytix Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Intralytix Revenue Proportion of Bacteriophage by Product in 2024
 Table 64. Intralytix Revenue Proportion of Bacteriophage by Application in 2024
 Table 65. Intralytix Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 66. Intralytix Recent Developments
 Table 67. MicroMir Corporation Information
 Table 68. MicroMir Description and Business Overview
 Table 69. MicroMir Bacteriophage Product
 Table 70. MicroMir Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. MicroMir Revenue Proportion of Bacteriophage by Product in 2024
 Table 72. MicroMir Revenue Proportion of Bacteriophage by Application in 2024
 Table 73. MicroMir Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 74. MicroMir Recent Developments
 Table 75. Phagelux Corporation Information
 Table 76. Phagelux Description and Business Overview
 Table 77. Phagelux Bacteriophage Product
 Table 78. Phagelux Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Phagelux Revenue Proportion of Bacteriophage by Product in 2024
 Table 80. Phagelux Revenue Proportion of Bacteriophage by Application in 2024
 Table 81. Phagelux Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 82. Phagelux Recent Developments
 Table 83. Pharmex Group, LLC Corporation Information
 Table 84. Pharmex Group, LLC Description and Business Overview
 Table 85. Pharmex Group, LLC Bacteriophage Product
 Table 86. Pharmex Group, LLC Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Pharmex Group, LLC Revenue Proportion of Bacteriophage by Product in 2024
 Table 88. Pharmex Group, LLC Revenue Proportion of Bacteriophage by Application in 2024
 Table 89. Pharmex Group, LLC Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 90. Pharmex Group, LLC Recent Developments
 Table 91. APS Biocontrol Ltd. (APS) Corporation Information
 Table 92. APS Biocontrol Ltd. (APS) Description and Business Overview
 Table 93. APS Biocontrol Ltd. (APS) Bacteriophage Product
 Table 94. APS Biocontrol Ltd. (APS) Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. APS Biocontrol Ltd. (APS) Revenue Proportion of Bacteriophage by Product in 2024
 Table 96. APS Biocontrol Ltd. (APS) Revenue Proportion of Bacteriophage by Application in 2024
 Table 97. APS Biocontrol Ltd. (APS) Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 98. APS Biocontrol Ltd. (APS) Recent Developments
 Table 99. ACD Pharma Corporation Information
 Table 100. ACD Pharma Description and Business Overview
 Table 101. ACD Pharma Bacteriophage Product
 Table 102. ACD Pharma Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. ACD Pharma Revenue Proportion of Bacteriophage by Product in 2024
 Table 104. ACD Pharma Revenue Proportion of Bacteriophage by Application in 2024
 Table 105. ACD Pharma Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 106. ACD Pharma Recent Developments
 Table 107. Proteon Pharmaceuticals Corporation Information
 Table 108. Proteon Pharmaceuticals Description and Business Overview
 Table 109. Proteon Pharmaceuticals Bacteriophage Product
 Table 110. Proteon Pharmaceuticals Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Proteon Pharmaceuticals Revenue Proportion of Bacteriophage by Product in 2024
 Table 112. Proteon Pharmaceuticals Revenue Proportion of Bacteriophage by Application in 2024
 Table 113. Proteon Pharmaceuticals Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 114. Proteon Pharmaceuticals Recent Developments
 Table 115. Micreos Corporation Information
 Table 116. Micreos Description and Business Overview
 Table 117. Micreos Bacteriophage Product
 Table 118. Micreos Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Micreos Revenue Proportion of Bacteriophage by Product in 2024
 Table 120. Micreos Revenue Proportion of Bacteriophage by Application in 2024
 Table 121. Micreos Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 122. Micreos Recent Developments
 Table 123. Locus Biosciences, Inc Corporation Information
 Table 124. Locus Biosciences, Inc Description and Business Overview
 Table 125. Locus Biosciences, Inc Bacteriophage Product
 Table 126. Locus Biosciences, Inc Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Locus Biosciences, Inc Revenue Proportion of Bacteriophage by Product in 2024
 Table 128. Locus Biosciences, Inc Revenue Proportion of Bacteriophage by Application in 2024
 Table 129. Locus Biosciences, Inc Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 130. Locus Biosciences, Inc Recent Developments
 Table 131. NexaBiome Limited Corporation Information
 Table 132. NexaBiome Limited Description and Business Overview
 Table 133. NexaBiome Limited Bacteriophage Product
 Table 134. NexaBiome Limited Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. NexaBiome Limited Revenue Proportion of Bacteriophage by Product in 2024
 Table 136. NexaBiome Limited Revenue Proportion of Bacteriophage by Application in 2024
 Table 137. NexaBiome Limited Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 138. NexaBiome Limited Recent Developments
 Table 139. PhagePro Corporation Information
 Table 140. PhagePro Description and Business Overview
 Table 141. PhagePro Bacteriophage Product
 Table 142. PhagePro Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. PhagePro Revenue Proportion of Bacteriophage by Product in 2024
 Table 144. PhagePro Revenue Proportion of Bacteriophage by Application in 2024
 Table 145. PhagePro Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 146. PhagePro Recent Developments
 Table 147. BiomX Corporation Information
 Table 148. BiomX Description and Business Overview
 Table 149. BiomX Bacteriophage Product
 Table 150. BiomX Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. BiomX Revenue Proportion of Bacteriophage by Product in 2024
 Table 152. BiomX Revenue Proportion of Bacteriophage by Application in 2024
 Table 153. BiomX Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 154. BiomX Recent Developments
 Table 155. INtODEWORLD, Inc. Corporation Information
 Table 156. INtODEWORLD, Inc. Description and Business Overview
 Table 157. INtODEWORLD, Inc. Bacteriophage Product
 Table 158. INtODEWORLD, Inc. Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 159. INtODEWORLD, Inc. Revenue Proportion of Bacteriophage by Product in 2024
 Table 160. INtODEWORLD, Inc. Revenue Proportion of Bacteriophage by Application in 2024
 Table 161. INtODEWORLD, Inc. Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 162. INtODEWORLD, Inc. Recent Developments
 Table 163. TechnoPhage Corporation Information
 Table 164. TechnoPhage Description and Business Overview
 Table 165. TechnoPhage Bacteriophage Product
 Table 166. TechnoPhage Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 167. TechnoPhage Revenue Proportion of Bacteriophage by Product in 2024
 Table 168. TechnoPhage Revenue Proportion of Bacteriophage by Application in 2024
 Table 169. TechnoPhage Revenue Proportion of Bacteriophage by Geographic Area in 2024
 Table 170. TechnoPhage Recent Developments
 Table 171. North America Bacteriophage Revenue by Country (2020-2025) & (US$ Million)
 Table 172. North America Bacteriophage Revenue by Country (2026-2031) & (US$ Million)
 Table 173. North America Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 174. North America Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 175. Asia-Pacific Bacteriophage Revenue by Region (2020-2025) & (US$ Million)
 Table 176. Asia-Pacific Bacteriophage Revenue by Region (2026-2031) & (US$ Million)
 Table 177. Asia-Pacific Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 178. Asia-Pacific Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 179. Europe Bacteriophage Revenue by Country (2020-2025) & (US$ Million)
 Table 180. Europe Bacteriophage Revenue by Country (2026-2031) & (US$ Million)
 Table 181. Europe Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 182. Europe Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 183. Latin America Bacteriophage Revenue by Country (2020-2025) & (US$ Million)
 Table 184. Latin America Bacteriophage Revenue by Country (2026-2031) & (US$ Million)
 Table 185. Latin America Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 186. Latin America Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 187. Middle East and Africa Bacteriophage Revenue by Country (2020-2025) & (US$ Million)
 Table 188. Middle East and Africa Bacteriophage Revenue by Country (2026-2031) & (US$ Million)
 Table 189. Middle East and Africa Bacteriophage Revenue by Type (2020-2025) & (US$ Million)
 Table 190. Middle East and Africa Bacteriophage Revenue by Application (2020-2025) & (US$ Million)
 Table 191. Bacteriophage Key Raw Materials, Industry Status and Trend
 Table 192. Bacteriophage Key Raw Materials and Upstream Suppliers
 Table 193. Bacteriophage Clients Status and Trend
 Table 194. Bacteriophage Typical Clients
 Table 195. Bacteriophage Distributors
 Table 196. Bacteriophage Market Trends
 Table 197. Bacteriophage Market Drivers
 Table 198. Bacteriophage Market Challenges
 Table 199. Bacteriophage Market Restraints
 Table 200. Research Programs/Design for This Report
 Table 201. Key Data Information from Secondary Sources
 Table 202. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bacteriophage Product Picture
 Figure 2. Global Bacteriophage Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Bacteriophage Revenue Market Share by Type in 2024 & 2031
 Figure 4. DsDNA Bacteriophage Product Picture
 Figure 5. SsDNA Bacteriophage Product Picture
 Figure 6. SsRNA Bacteriophage Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Bacteriophage Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Bacteriophage Revenue Market Share by Application in 2024 & 2031
 Figure 10. Animal Health
 Figure 11. Aquaculture
 Figure 12. Agriculture
 Figure 13. Food Industry
 Figure 14. Human Health
 Figure 15. Others
 Figure 16. Bacteriophage Report Years Considered
 Figure 17. Global Bacteriophage Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Bacteriophage Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Bacteriophage Market Size Market Share by Region: 2024 Versus 2031
 Figure 20. Global Bacteriophage Revenue Market Share by Region (2020-2031)
 Figure 21. Global Bacteriophage Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Global Bacteriophage Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. DsDNA Bacteriophage of Bacteriophage Revenue Market Share by Application, 2024 VS 2031
 Figure 24. SsDNA Bacteriophage of Bacteriophage Revenue Market Share by Application, 2024 VS 2031
 Figure 25. SsRNA Bacteriophage of Bacteriophage Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Others of Bacteriophage Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Bacteriophage Revenue Share by Company (2024)
 Figure 28. Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. DsDNA Bacteriophage Revenue Proportion by Company in 2024
 Figure 30. SsDNA Bacteriophage Revenue Proportion by Company in 2024
 Figure 31. SsRNA Bacteriophage Revenue Proportion by Company in 2024
 Figure 32. Others Revenue Proportion by Company in 2024
 Figure 33. North America Bacteriophage Revenue 2020-2031 (US$ Million)
 Figure 34. North America Bacteriophage Revenue Market Share by Type (2020-2025)
 Figure 35. North America Bacteriophage Revenue Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Bacteriophage Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Bacteriophage Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Bacteriophage Revenue Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Bacteriophage Revenue Market Share by Application (2020-2025)
 Figure 40. Europe Bacteriophage Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Bacteriophage Revenue Market Share by Country (2020-2031)
 Figure 42. Europe Bacteriophage Revenue Market Share by Type (2020-2025)
 Figure 43. Europe Bacteriophage Revenue Market Share by Application (2020-2025)
 Figure 44. Latin America Bacteriophage Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Latin America Bacteriophage Revenue Market Share by Country (2020-2031)
 Figure 46. Latin America Bacteriophage Revenue Market Share by Type (2020-2025)
 Figure 47. Latin America Bacteriophage Revenue Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Bacteriophage Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Bacteriophage Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Bacteriophage Revenue Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Bacteriophage Revenue Market Share by Application (2020-2025)
 Figure 52. Bacteriophage Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Bacteriophage Raw Materials by Region in 2024
 Figure 54. Bacteriophage Distribution Channels
 Figure 55. Global Bacteriophage Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Bacteriophage Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Bacteriophages Therapy Service Market Insights Forecast to 2030
Global Phage Therapy Market Research Report 2024
Bacteriophages Phage Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bacteriophage Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bacteriophages Phage Feed Additives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ds DNA Bacteriophage Market Insights Forecast to 2030
Global Phage Therapy Kits Market Research Report 2024
Bacteriophage Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bactericide Market
Global Antimicrobial Therapeutics Market Insights Forecast to 2030
Global Phage DNA Isolation Kit Market Research Report 2024
Global Phage Display based Antibody Discovery Platform Market Research Report 2025
Global Bacteriostatic Antibiotics Market Insights Forecast to 2030
Global Oncolytic Virus Market Insights Forecast to 2030
Global Antibacterial Masks Market Insights Forecast to 2030
Global Bacteremia Market Insights Forecast to 2030
Global Chloramphenicol Market Insights Forecast to 2030
Global Antimicrobial Formulations Market Research Report 2024
Global Biomolecule Software Market Research Report 2024
Global Disinfection Supplies Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions